CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO EBITDA Margin

EBITDA as a percentage of revenue.

CareRx CorporationTSX: CRRX.TO

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 8.5%

EBITDA Margin was 8.5% in Q1 FY2026, up 0.9 pp from a year earlier. On a trailing-twelve-month basis it was 8.0%, up 1.5 pp year over year. Over 3 fiscal years it widened by 8.3 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 8.3% for the fiscal year ending Dec 2026, up from 8.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
8.5%+0.6 pp QoQ
Last fiscal yearDec 2025
8.2%+1.6 pp YoY
LTMMar 2026
8.0%+1.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.9 pp+0.7 pp-0.3 pp
1 year+1.6 pp+0.2 pp-1.5 pp
3 years+8.3 pp+1.2 pp-7.2 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.2%
Year-over-year change
+1.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • CRRX.TO's LTM Mar 2026 EBITDA Margin of 8.0% is the 4th highest of the 5 companies compared; the peer median is 27.9%.
  • Its year-over-year change of +1.5 pp is the 4th highest of 5, against a peer median of +5.6 pp.
  • Over three fiscal years its change of +8.3 pp compares with a peer median of +72.2 pp.
CRRX.TO Competitors Peer median
EBITDA Margin for CRRX.TO and competitors
Company Period LTM level YoY 3-year change
HLS.TOHLS Therapeutics Inc.LTM Mar 202631.9% +6.2 pp+2.6 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202631.0% +5.0 pp+133.5 pp
DR.TOMedical Facilities CorporationLTM Mar 202624.7% -1.0 pp+10.9 pp
CRRX.TOCareRx CorporationLTM Mar 20268.0% +1.5 pp+8.3 pp
PRN.TOProfound Medical Corp.LTM Mar 2026-194.3% +121.3 pp+145.4 pp
HBP.TOHelix BioPharma Corp.FY2025— ——
Peer median (excluding CRRX.TO) 27.9%+5.6 pp+72.2 pp

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue262.63M381.73M370.75M366.71M370.24M
Cost of Revenue187.35M271.79M286.02M258.65M277.61M
Gross Profit75.28M109.93M84.72M108.06M92.63M
Gross Margin28.7%28.8%22.9%29.5%25.0%
Research & Development00000
Selling, General & Admin70.52M102.55M77.5M32.75M34.23M
Operating Expenses70.47M82.24M100.03M103.54M80.75M
Depreciation & Amortization15.39M20.07M19.98M19.19M18.33M
EBITDA9.01M(610K)24.65M23.9M30.22M
EBITDA Margin3.4%-0.2%6.6%6.5%8.2%
Operating Income(3.31M)(21.94M)4.67M4.53M11.88M
Operating Margin-1.3%-5.7%1.3%1.2%3.2%
Interest Income58K278K1.26M63K161K
Interest Expense17.35M15.22M14.27M9.18M6.84M
Other Income / Expenses(20.43M)(13.95M)(14.27M)(8.99M)(8.53M)
Income Before Tax(23.74M)(35.9M)(9.6M)(4.47M)3.35M
Pre-Tax Margin-9.0%-9.4%-2.6%-1.2%0.9%
Income Tax Expense(1.01M)(1.54M)(4.19M)32K(22.77M)
Net Income(22.73M)(34.35M)(5.41M)(4.5M)26.13M
Net Margin-8.7%-9.0%-1.5%-1.2%7.1%
EPS (Basic)(0.65)(0.72)(0.09)(0.07)0.42
EPS (Diluted)(0.65)(0.72)(0.09)(0.07)0.41
Weighted Avg Shares34.86M47.6M57.35M60.25M62.73M
Weighted Avg Shares (Diluted)34.86M47.6M57.35M60.25M64.49M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.